Posner Christopher (CIK 1748265) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-03-04). Recent activity: Sell CARA (583 shares), Sell CARA (372 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-04 | Cara Therapeutics, Inc. (CARA) | PRESIDENT AND CEO | Sell | 583 | $2,769 |
| 2025-02-06 | Cara Therapeutics, Inc. (CARA) | PRESIDENT AND CEO | Sell | 372 | $1,756 |
Source: SEC Form 4 filings · as of 2025-03-04